Your browser doesn't support javascript.
loading
Oral S-1 with 24-h Infusion of Irinotecan plus Bevacizumab versus FOLFIRI plus Bevacizumab as First-Line Chemotherapy for Metastatic Colorectal Cancer: An Open-Label Randomized Phase II Trial.
Sadahiro, Sotaro; Suzuki, Toshiyuki; Okada, Kazutake; Saito, Gota; Miyakita, Hiroshi; Ogimi, Takashi; Chan, Lin Fung; Kamei, Yutaro.
Afiliação
  • Sadahiro S; Department of Surgery, Tokai University, School of Medicine, Isehara, Japan, sadahiro@is.icc.u-tokai.ac.jp.
  • Suzuki T; Department of Surgery, Tokai University, School of Medicine, Isehara, Japan.
  • Okada K; Department of Surgery, Tokai University, School of Medicine, Isehara, Japan.
  • Saito G; Department of Surgery, Tokai University, School of Medicine, Isehara, Japan.
  • Miyakita H; Department of Surgery, Tokai University, School of Medicine, Isehara, Japan.
  • Ogimi T; Department of Surgery, Tokai University, School of Medicine, Isehara, Japan.
  • Chan LF; Department of Surgery, Tokai University, School of Medicine, Isehara, Japan.
  • Kamei Y; Department of Surgery, Tokai University, School of Medicine, Isehara, Japan.
Oncology ; 98(9): 637-642, 2020.
Article em En | MEDLINE | ID: mdl-32474564

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article